Hanusch-Krankenhaus Der Wiener Gebietskrankenkasse

Vienna 01140

0 studies enrolling now · 2 studies all time

What they study most

Chronic Lymphocytic Leukemia, Myelofibrosis, Non Hodgkin Lymphoma, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Studies at this site

• A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL) — Stopped early
• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early